Global Graves’ Disease (Overactive Thyroid) Market Size, Share, and COVID-19 Impact Analysis, By Treatment (Anti-Thyroid Drugs, Beta Blockers, Iodine Therapy, Radioactive Iodine Therapy, Others), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

1. Introduction
   1. Objectives of the Study
   2. Market Definition
   3. Research Scope
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
   1. Porter’s Five Forces Analysis
   2. Value Chain Analysis
   3. Top Investment Pockets
      1. Market Attractiveness Analysis By Treatment
      2. Market Attractiveness Analysis By Route of Administration
      3. Market Attractiveness Analysis By Distribution Channel
      4. Market Attractiveness Analysis By Region
   4. Industry Trends
5. Market Dynamics
   1. Market Evaluation
   2. Drivers
      1. Increase in Heart issues are among the many harmful side effects of hyperthyroidism
   3. Restraints
      1.  High cost of treatment
   4. Opportunities
      1.  Increase in the number of research and development activities
   5. Challenges

5.5.1.   lack of healthcare infrastructure

1. Global Graves’ Disease (Overactive Thyroid) Market Analysis and Projection, By Treatment
   1. Segment Overview
   2. Anti-Thyroid Drugs
   3. Beta Blockers
   4. Iodine Therapy
   5. Radioactive Iodine Therapy
   6. Others
2. Global Graves’ Disease (Overactive Thyroid) Market Analysis and Projection, By Route of Administration
   1. Segment Overview
   2. Oral
   3. Parenteral
   4. Others
3. Global Graves’ Disease (Overactive Thyroid) Market Analysis and Projection, By Distribution Channel
   1. Segment Overview
   2. Hospital Pharmacies
   3. Retail Pharmacies
   4. Online Pharmacies
4. Global Graves’ Disease (Overactive Thyroid) Market Analysis and Projection, By Regional Analysis
   1. Segment Overview
   2. North America
      1. U.S.
      2. Canada
      3. Mexico
   3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
   4. Asia-Pacific
      1. Japan
      2. China
      3. India
   5. South America
      1. Brazil
   6. Middle East and Africa
      1. UAE
      2. South Africa
5. Global Graves’ Disease (Overactive Thyroid) Market-Competitive Landscape
   1. Overview
   2. Market Share of Key Players in the Graves’ Disease (Overactive Thyroid) Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
   3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
6. Company Profiles
   1. Allergan
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   2.   AstraZeneca 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   3.  Sling Therapeutics, Inc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   4.   Johnson & Johnson Private Limited 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   5.   Hikma Pharmaceuticals PLC 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   6.  Merck KGaA
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   7.   Novartis AG
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   8. Mindray
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   9.  HanAll Biopharma Co., Ltd.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
   10.  Mylan N.V. 
       1. Business Overview
       2. Company Snapshot
       3. Company Market Share Analysis
       4. Company Coverage Portfolio
       5. Recent Developments
       6. SWOT Analysis
   11.  Aspen Pharmacare Holdings Ltd
       1. Business Overview
       2. Company Snapshot
       3. Company Market Share Analysis
       4. Company Coverage Portfolio
       5. Recent Developments
       6. SWOT Analysis
   12.   GlaxoSmithKline plc
       1. Business Overview
       2. Company Snapshot
       3. Company Market Share Analysis
       4. Company Coverage Portfolio
       5. Recent Developments
       6. SWOT Analysis
   13.  Horizon Therapeutics plc 
       1. Business Overview
       2. Company Snapshot
       3. Company Market Share Analysis
       4. Company Coverage Portfolio
       5. Recent Developments
       6. SWOT Analysis
   14.  Alara Pharmaceutical Corporation
       1. Business Overview
       2. Company Snapshot
       3. Company Market Share Analysis
       4. Company Coverage Portfolio
       5. Recent Developments
       6. SWOT Analysis
   15. Others
       1. Business Overview
       2. Company Snapshot
       3. Company Market Share Analysis
       4. Company Coverage Portfolio
       5. Recent Developments
       6. SWOT Analysis

1. Global Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
2. Global Anti-Thyroid Drugs, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
3. Global Beta Blockers, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
4. Global Iodine Therapy, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
5. Global Radioactive Iodine Therapy, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
6. Global Others, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
7. Global Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
8. Global Oral, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
9. Global Parenteral, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
10. Global Others, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
11. Global Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
12. Global Hospital Pharmacies, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
13. Global Retail Pharmacies, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
14. Global Online Pharmacies, Graves’ Disease (Overactive Thyroid) Market, By Region, 2023-2033(USD Billion)
15. North America Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
16. North America Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
17. North America Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
18. U.S.  Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
19. U.S.  Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
20. U.S.  Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
21. Canada Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
22. Canada Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
23. Canada Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
24. Mexico Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
25. Mexico Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
26. Mexico Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
27. Europe Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
28. Europe Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
29. Europe Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
30. Germany Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
31. Germany Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
32. Germany Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
33. France Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
34. France Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
35. France Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
36. U.K.  Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
37. U.K.  Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
38. U.K.  Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
39. Italy Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
40. Italy Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
41. Italy Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
42. Spain Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
43. Spain Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
44. Spain Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
45. Asia Pacific Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
46. Asia Pacific Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
47. Asia Pacific Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
48. Japan Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
49. Japan Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
50. Japan Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
51. China Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
52. China Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
53. China Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
54. India Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
55. India Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
56. India Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
57. South America Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
58. South America Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
59. South America Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
60. Brazil Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
61. Brazil Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
62. Brazil Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
63. The Middle East and Africa Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD   Billion)
64. The Middle East and Africa Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD   Billion)
65. The Middle East and Africa Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
66. UAE Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
67. UAE Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
68. UAE Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)
69. South Africa Graves’ Disease (Overactive Thyroid) Market, By Treatment, 2023-2033(USD Billion)
70. South Africa Graves’ Disease (Overactive Thyroid) Market, By Route of Administration, 2023-2033(USD Billion)
71. South Africa Graves’ Disease (Overactive Thyroid) Market, By Distribution Channel, 2023-2033(USD Billion)

1. Global Graves’ Disease (Overactive Thyroid) Market Segmentation
2. Graves’ Disease (Overactive Thyroid) Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Top investment pocket in the Graves’ Disease (Overactive Thyroid) Market
9. Top Winning Strategies, 2023-2033
10. Top Winning Strategies, By Development, 2023-2033(%)
11. Top Winning Strategies, By Company, 2023-2033
12. Moderate Bargaining power of Buyers
13. Moderate Bargaining power of Suppliers
14. Moderate Bargaining power of New Entrants
15. Low threat of Substitution
16. High Competitive Rivalry
17. Top Player Positioning, 2023
18. Market Share Analysis, 2023
19. Restraint and Drivers:  Graves’ Disease (Overactive Thyroid) Market
20. Graves’ Disease (Overactive Thyroid) Market Segmentation, By Treatment
21. Graves’ Disease (Overactive Thyroid) Market For Anti-Thyroid Drugs, By Region, 2023-2033 ($ Billion)
22.  Graves’ Disease (Overactive Thyroid) Market For Beta Blockers, By Region, 2023-2033 ($ Billion)
23. Graves’ Disease (Overactive Thyroid) Market For Iodine Therapy, By Region, 2023-2033 ($ Billion)
24. Graves’ Disease (Overactive Thyroid) Market For Radioactive Iodine Therapy, By Region, 2023-2033 ($ Billion)
25. Graves’ Disease (Overactive Thyroid) Market For Others, By Region, 2023-2033 ($ Billion)
26.  Graves’ Disease (Overactive Thyroid) Market Segmentation, By Route of Administration
27.  Graves’ Disease (Overactive Thyroid) Market For Oral, By Region, 2023-2033 ($ Billion)
28.  Graves’ Disease (Overactive Thyroid) Market For Parenteral, By Region, 2023-2033 ($ Billion)
29. Graves’ Disease (Overactive Thyroid) Market For Others, By Region, 2023-2033 ($ Billion)
30. Graves’ Disease (Overactive Thyroid) Market Segmentation, By Distribution Channel
31. Graves’ Disease (Overactive Thyroid) Market For Hospital Pharmacies, By Region, 2023-2033 ($ Billion)
32. Graves’ Disease (Overactive Thyroid) Market For Retail Pharmacies, By Region, 2023-2033 ($ Billion)
33. Graves’ Disease (Overactive Thyroid) Market For Online Pharmacies, By Region, 2023-2033 ($ Billion)
34. Allergan: Net Sales, 2023-2033 ($ Billion)
35. Allergan: Revenue Share, By Segment, 2023 (%)
36. Allergan: Revenue Share, By Region, 2023 (%)
37. AstraZeneca: Net Sales, 2023-2033 ($ Billion)
38. AstraZeneca: Revenue Share, By Segment, 2023 (%)
39. AstraZeneca: Revenue Share, By Region, 2023 (%)
40. Sling Therapeutics, Inc: Net Sales, 2023-2033 ($ Billion)
41. Sling Therapeutics, Inc: Revenue Share, By Segment, 2023 (%)
42. Sling Therapeutics, Inc: Revenue Share, By Region, 2023 (%)
43. Johnson & Johnson Private Limited: Net Sales, 2023-2033 ($ Billion)
44. Johnson & Johnson Private Limited: Revenue Share, By Segment, 2023 (%)
45. Johnson & Johnson Private Limited: Revenue Share, By Region, 2023 (%)
46. Hikma Pharmaceuticals PLC: Net Sales, 2023-2033 ($ Billion)
47. Hikma Pharmaceuticals PLC: Revenue Share, By Segment, 2023 (%)
48. Hikma Pharmaceuticals PLC: Revenue Share, By Region, 2023 (%)
49. Merck KGaA: Net Sales, 2023-2033 ($ Billion)
50. Merck KGaA: Revenue Share, By Segment, 2023 (%)
51. Merck KGaA: Revenue Share, By Region, 2023 (%)
52. Novartis AG: Net Sales, 2023-2033 ($ Billion)
53. Novartis AG: Revenue Share, By Segment, 2023 (%)
54. Novartis AG: Revenue Share, By Region, 2023 (%)
55. Mindray: Net Sales, 2023-2033 ($ Billion)
56. Mindray: Revenue Share, By Segment, 2023 (%)
57. Mindray: Revenue Share, By Region, 2023 (%)
58. HanAll Biopharma Co., Ltd..: Net Sales, 2023-2033 ($ Billion)
59. HanAll Biopharma Co., Ltd..: Revenue Share, By Segment, 2023 (%)
60. HanAll Biopharma Co., Ltd..: Revenue Share, By Region, 2023 (%)
61. Mylan N.V.: Net Sales, 2023-2033 ($ Billion)
62. Mylan N.V.: Revenue Share, By Segment, 2023 (%)
63. Mylan N.V.: Revenue Share, By Region, 2023 (%)
64. Aspen Pharmacare Holdings Ltd: Net Sales, 2023-2033 ($ Billion)
65. Aspen Pharmacare Holdings Ltd: Revenue Share, By Segment, 2023 (%)
66. Aspen Pharmacare Holdings Ltd: Revenue Share, By Region, 2023 (%)
67. GlaxoSmithKline plc: Net Sales, 2023-2033 ($ Billion)
68. GlaxoSmithKline plc: Revenue Share, By Segment, 2023 (%)
69. GlaxoSmithKline plc: Revenue Share, By Region, 2023 (%)
70. Horizon Therapeutics plc: Net Sales, 2023-2033 ($ Billion)
71. Horizon Therapeutics plc: Revenue Share, By Segment, 2023 (%)
72. Horizon Therapeutics plc: Revenue Share, By Region, 2023 (%)
73. Alara Pharmaceutical Corporation: Net Sales, 2023-2033 ($ Billion)
74. Alara Pharmaceutical Corporation: Revenue Share, By Segment, 2023 (%)
75. Alara Pharmaceutical Corporation: Revenue Share, By Region, 2023 (%)
76. Others: Net Sales, 2023-2033 ($ Billion)
77. Others: Revenue Share, By Segment, 2023 (%)
78. Others: Revenue Share, By Region, 2023 (%)